Short-term effects of ocrelizumab on cortical pathology in patients with multiple sclerosis.

Cavalli N, Boffa G, Cipriano E, Boccia VD, Al Qudsi S, Baldisseri F, Leveraro E, Nasone L, Magon S, Cellerino M, et al.